Queensland cultivator The People’s Plant has raised close to $1.2 million from almost 702 investors in its latest crowdfunding raise.
The offer, which closes later today, aims to fund the fit out of its Sunshine Coast facility as it moves towards commercialisation in 2027.
Shares in the start-up grower went on sale last week at $1.25 per share, with hopes of raising $2 million.
As of 10.40am today, The People’s Plant had raised $1.19m with 13 hours of the offer to run.
It’s the fourth crowdfunding campaign undertaken by the company and brings the total raised through CSF platforms to $5m.
Medigrowth
Medigrowth has become an official Endometriosis-friendly workplace after completing an accreditation program with Endometriosis Australia.
The EndoThrive initiative is designed to build awareness and provide guidance and advice in how firms can support staff suffering from the condition.
Despite affecting an estimated one in seven women in Australia, endometriosis is often overlooked in the workplace, the advocacy group says.
Studies have delivered promising results in treating the symptoms of endometriosis with Medicinal cannabis.
“Symptoms can affect attendance, performance, career progression, and psychological safety, long before employees feel safe to ask for support,” the Endometriosis Australia website states.
Medigrowth chief executive Adam Guskich said: “Our core mission has always been to improve quality of life, and we know firsthand how devastating endometriosis can be for patients. But true advocacy starts from within. We cannot champion patient care without first ensuring our own team members feel safe, supported, and understood when managing chronic pain.”
Medigrowth medical and research director Dr Ashleigh Osborne said was proud of how staff approached the program.
“Launching this initiative was deeply important to myself and our founders, but seeing the overwhelming enthusiasm and empathy from our staff has been truly rewarding,” she said.